Header graphic for print
LimeGreenIP News

Tag Archives: Allergan

US – Patent IPRs: Sovereign immunity defence heading on up?

In this post, we discuss the sovereign immunity defence for IPRs which has garnered much attention, with the final chapter likely ending up at SCOTUS. The article was first published in Intellectual Property Magazine, April 2018. Summary So how does the sovereign immunity saga end? The PTAB and Congress have already made their scepticism of tribal